Key populations brief
Accessed November 2017
How to make your messages on tuberculosis count
WHO/HTM/STB/2009.57
Advocacy, communication and social mobilization for TB control
Advocacy report March 2011
303100 03/2011 E 1,000
For Children and their Families
October 2015
Key populations brief
Accessed 2017
Informe sobre poblaciones clave.
Rappart sur les populations clés.
Vision 2030
Accessed: 17.11.2019
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, ...including longer and shorter regimens, culture monitoring of patients on treatment, the timing of antiretroviral therapy (ART) in MDR/RR-TB patients infected with the human immunodeficiency virus (HIV), use of surgery for patients receiving MDR-TB treatment, and optimal models of patient support and care.
more
GDF is the largest global provider of quality-assured tuberculosis (TB)
medicines, diagnostics, and laboratory supplies to the public sector.
Since 2001, GDF has facilitated access to high-quality TB care in over 130
countries, providing treatments to over 30 million people with TB and procuring
...
and delivering more than $200 million worth of diagnostic equipment
more